Sfoglia per AUTORE
TROJANO M
Collezione AOU San Luigi di Orbassano

  

Items : 25

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register]. in Epidemiologia e prevenzione / Epidemiol Prev. 2024 Jul-Oct;48(4-5):361-374. doi: 10.19191/EP24.4-5.A734.074.
2024
AOU Alessandria
AO Cuneo
ASL Cuneo 1
ASL Città di Torino
ASL Torino 4
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Mosconi P; Lepore V; Paletta P; Trojano M; Salivetto M; D'Ettorre A; Corrado D; Battaglia MA; Ponzio M;

Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano

Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...

COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients. in Journal of neurology / J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20.
2024
AOU San Luigi di Orbassano

Mascolo A; Copetti M; Trojano M; Patti F; Mirabella M; Marfia GA; Lus G; Granella F; Filippi M; De Luca G; Capobianco M; Matrone F; Bisecco A; Tedeschi G; Gallo A;

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2024 Aug;11(8):2008-2015. doi: 10.1002/acn3.52118. Epub 2024 Jul 5.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Brescia Morra V; Cocco E; Torri Clerici V; Spitaleri D; Clerici R; Vianello M; Quatrale R; Di Sapio A; Montepietra S; Gallo A; Bellantonio P; Gallo P; De Luca G; Cavalla P; Romano S; Granella F; Patti F; Foschi M; Inglese M; Portaccio E; Paolicelli D; Guerra T; Lucisano G; Iaffaldano P; Marfia GA; Boccia VD; Filippi M; Amato MP; Trojano M; et alii...

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. in Journal of neurology / J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5.
2023
AOU San Luigi di Orbassano

Amato MP; Bergamaschi R; Centonze D; Mirabella M; Marfia GA; Totaro R; Lus G; Brescia Morra V; Aguglia U; Comi C; Cavalla P; Zaffaroni M; Rovaris M; Grimaldi LM; Leoni S; Malucchi S; Baldi E; Romano M; Falcini M; Perini P; Assetta M; Portaccio E; Sommacal S; Olivieri N; Parodi F; Todaro DS; Grassivaro N; Farina A; Mondino MM; et alii...

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. in Journal of neurology / J Neurol. 2022 Mar;269(3):1463-1469. doi: 10.1007/s00415-021-10708-1. Epub 2021 Jul 22.
2022
AOU San Luigi di Orbassano

Vitetta F; Pisano E; Malucchi S; Cavalla P; Cellerino M; Patti F; Lus G; Mirabella M; Zaffaroni M; Brescia Morra V; Capobianco M; Inglese M; Guerra T; Iaffaldano P; Ferraro D; Paolicelli D; Sola P; Trojano M;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Jul;63:103909. doi: 10.1016/j.msard.2022.103909. Epub 2022 May 25.
2022
AOU San Luigi di Orbassano

Ponzano M; Schiavetti I; Bovis F; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Bragadin MM; Cocco E; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Bergamaschi R; Inglese M; Petracca M; Trojano M; Tedeschi G; Comi G; Battaglia MA; Patti F; Fragoso YD; Sen S; Siva A; et alii...

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 20
2022
AOU San Luigi di Orbassano

Sormani MP; Schiavetti I; Carmisciano L; Cordioli C; Filippi M; Radaelli M; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Cocco E; Scandellari C; Cavalla P; Pesci I; Zito A; Confalonieri P; Marfia GA; Perini P; Inglese M; Trojano M; Brescia Morra V; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; Schiavetti I; Carmisciano L; et alii...

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Feb;29(2):535-542. doi: 10.1111/ene.15167. Epub 2021 Nov 15.
2022
AOU San Luigi di Orbassano

Tedeschi G; Pisoni E; Brescia Morra V; Trojano M; Inglese M; Perini P; Marfia GA; Confalonieri P; Zito A; Cavalla P; Pesci I; Scandellari C; Cocco E; Brichetto G; De Rossi N; Capobianco M; Immovilli P; Radaelli M; Filippi M; Carmisciano L; Cordioli C; Schiavetti I; Ponzano M; Bergamaschi R; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; et alii...

Signs and symptoms of COVID-19 in patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23.
2022
AOU San Luigi di Orbassano

Schiavetti I; Carmisciano L; Ponzano M; Cordioli C; Cocco E; Marfia GA; Inglese M; Filippi M; Radaelli M; Bergamaschi R; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Trojano M; Lanzillo R; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP;

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Sormani MP; Salvetti M; Labauge P; Schiavetti I; Zephir H; Carmisciano L; Bensa C; De Rossi N; Pelletier J; Cordioli C; Vukusic S; Moiola L; Kerschen P; Radaelli M; Théaudin M; Immovilli P; Casez O; Capobianco M; Ciron J; Trojano M; Stankoff B; Créange A; Tedeschi G; Clavelou P; Comi G; Thouvenot E; Battaglia MA; Moreau T; Patti F; et alii...

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. in Annals of neurology / Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9.
2021
AOU San Luigi di Orbassano

Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M; Zaratin P; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M;

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. in Therapeutic advances in neurological disorders / Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollectio
2021
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Caputo F; Paolicelli D; Patti F; Zaffaroni M; Brescia Morra V; Pozzilli C; De Luca G; Inglese M; Salemi G; Maniscalco GT; Cocco E; Sola P; Lus G; Conte A; Amato MP; Granella F; Gasperini C; Bellantonio P; Totaro R; Rovaris M; Salvetti M; Torri Clerici VLA; Bergamaschi R; Maimone D; Scarpini E; Capobianco M; Comi G; et alii...

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2843-2851. doi: 10.1007/s10072-020-04380-y. Epub 2020 Apr 21.
2020
AOU San Luigi di Orbassano

Comi G; Pozzilli C; Morra VB; Bertolotto A; Sangalli F; Prosperini L; Carotenuto A; Iaffaldano P; Capobianco M; Colombo D; Nica M; Rizzoli S; Trojano M;

2019
AOU San Luigi di Orbassano

Paolicelli D; Lucisano G; Manni A; Avolio C; Bonavita S; Brescia Morra V; Capobianco M; Cocco E; Conte A; De Luca G; De Robertis F; Gasperini C; Gatto M; Gazzola P; Lus G; Iaffaldano A; Iaffaldano P; Maimone D; Mallucci G; Maniscalco GT; Marfia GA; Patti F; Pesci I; Pozzilli C; Rovaris M; Salemi G; Salvetti M; Spitaleri D; Totaro R; et alii...

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.
2019
AOU San Luigi di Orbassano

Lavie C; Rollot F; Durand-Dubief F; Marignier R; Ionescu I; Casey R; Moreau T; Tourniaire P; Hutchinson M; D'Hooghe MB; Laplaud DA; Clavelou P; De Sèze J; Debouverie M; Brassat D; Pelletier J; Lebrun-Frenay C; Le Page E; Castelnovo G; Berger E; Hautecoeur P; Heinzlef O; Durelli L; Clerico M; Trojano M; Patti F; Vukusic S;

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2018 Feb;39(2):395. doi: 10.1007/s10072-017-3226-9.
2018
AOU San Luigi di Orbassano

Amato MP; Bertolotto A; Brunelli R; Cavalla P; Goretti B; Marrosu MG; Patti F; Pozzilli C; Provinciali L; Rizzo N; Strobelt N; Tedeschi G; Trojano M; Comi G;

Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(10):1849-1858. doi: 10.1007/s10072-017-3081-8. Epub 2017 Aug 2.
2017
AOU San Luigi di Orbassano

Amato MP; Bertolotto A; Brunelli R; Cavalla P; Goretti B; Marrosu MG; Patti F; Pozzilli C; Provinciali L; Rizzo N; Strobelt N; Tedeschi G; Trojano M; Comi G;

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):944-51. doi: 10.1136/jnnp-2015-312591. Epub 2016 May 9
2016
AOU San Luigi di Orbassano

Patti F; Messina S; Solaro C; Amato MP; Bergamaschi R; Bonavita S; Bruno Bossio R; Brescia Morra V; Costantino GF; Cavalla P; Centonze D; Comi G; Cottone S; Danni M; Francia A; Gajofatto A; Gasperini C; Ghezzi A; Iudice A; Lus G; Maniscalco GT; Marrosu MG; Matta M; Mirabella M; Montanari E; Pozzilli C; Rovaris M; Sessa E; Spitaleri D; et alii...

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jun;13(6):799-805. doi: 10.1517/17425247.2016.1158161. Epub 2016 Mar 12
2016
AOU San Luigi di Orbassano

Paolicelli D; Cocco E; Di Lecce V; Direnzo V; Moiola L; Lanzillo R; Perini P; Malucchi S; Borriello G; Portaccio E; Panetta V; Fenu G; Sangalli F; Cacciaguerra L; Trojano M;

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis. in Brain : a journal of neurology / Brain. 2015 Nov;138(Pt 11):3275-86. doi: 10.1093/brain/awv260. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano

Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; et alii...

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.
2014
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Trojano M; Zaffaroni M; Malucchi S; Bertolotto A; Capobianco M; et alii...

2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Paolicelli D; Cavalla P; Sola P; Vitetta F; Realmuto S; Salemi G; Bianchi A; Ghezzi A; Lanzillo R; Brescia Morra V; Gned D; Piazza F; De Mercanti SF; Schiavetti I; Clerico M; Trojano M; Sormani MP; Durelli L;